Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder-Reference-Cited by-同舟云学术

Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder

Published:2010-02-01 Issue:3 Volume:116 Page:600-609
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ardelt Peter U.,Kneitz Burkhard,Adam Patrick,Reiss Cora,Kocot Arkadius,Fensterle Joachim,Chen Limor,Pasqualini Renata,Arap Wadih,Gerharz Elmar W.,Riedmiller Hubertus

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24770/fullpdf

Reference24 articles.

1. Routine transurethral biopsy of the bladder is not necessary to evaluate the response to bacillus Calmette-Guerin therapy;Murakami;Acta Med Okayama.,2007

2. Intracavitary bacillus Calmette-Guerin in the superficial bladder tumor;Morales;J Urol.,1976

3. Immunotherapeutic strategies for high-risk bladder cancer;Sharma;Semin Oncol.,2007

4. Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial;Herr;J Clin Oncol.,1995

5. BCG immunotherapy of bladder cancer: 20 years on;Alexandroff;Lancet.,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiota-Parasite Interaction: Implication of Secretory Immunoglobulin A and P2X7 Receptor Signaling;Discovery Medicine;2024

2. Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non–muscle-invasive Bladder Cancer;Clinical Genitourinary Cancer;2021-12

3. Immunogenic cell death inducers for enhanced cancer immunotherapy;Chemical Communications;2021

4. Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice;Scientific Reports;2018-10-10

5. Baseline Cytokine Profiles of Tuberculin-Specific CD4+ T Cells in Non–Muscle-Invasive Bladder Cancer May Predict Outcomes of BCG Immunotherapy;Cancer Immunology Research;2018-08-17